
EpiVax Oncology
EpiVax Oncology: A US-based biotech firm specializing in precision cancer immunotherapy vaccines.
- 5
- Pre-Seed
EpiVax Oncology, founded with a mission to revolutionize cancer treatment, focuses on developing precision cancer immunotherapy vaccines. The company specializes in creating mutanome-directed neo-epitope personalized therapeutic vaccines, aiming to provide tailored treatment options for cancer patients. EpiVax Oncology serves the U.S. market, leveraging advanced biotechnology to enhance the efficacy and specificity of cancer immunotherapies.
Notable affiliated individuals include experts in immunology and oncology, contributing to the company's innovative approach. EpiVax Oncology has garnered attention for its cutting-edge research and development in personalized cancer vaccines, positioning itself as a leader in precision medicine. The company's impact is reflected in its commitment to improving patient outcomes through highly targeted and individualized treatment strategies.
Similar Companies

Epivax
epivax.com

Cancervax
cancervax.com

Geneos Therapeutics
geneostx.com
Agilvax
agilvax.com

UbiVac
ubivac.com

MimiVax
mimivax.com

Irazu Oncology
irazuoncology.com

CellVax Therapeutics
cellvx.com

Revitope Oncology
revitope.com

OncoPep
oncopep.com

Curevax

Imvaq Therapeutics

Imvax
imvax.com

OncoPrecision
oncoprecision.bio

Adventris Pharmaceuticals
Quick Facts
Who are EpiVax Oncology's competitors?
Companies similar to EpiVax Oncology include Epivax, Cancervax, Geneos Therapeutics and Agilvax.
When was EpiVax Oncology founded?
EpiVax Oncology was founded in 2017.
Where is EpiVax Oncology's headquarters located?
EpiVax Oncology's headquarters is located in Providence, RI, US.
When was EpiVax Oncology's last funding round?
EpiVax Oncology's most recent funding round was for $1.2M (USD) in June 2018.
How much disclosed funding has EpiVax Oncology raised?
As of Jun 12, 2018, EpiVax Oncology has disclosed funding of $1.5M (USD). Undisclosed round amounts are excluded.
How many employees does EpiVax Oncology have?
EpiVax Oncology has 5 employees as of Feb 5, 2024.
Classification
- Ownership
- Technology
- Geographic Exposure
- Customer
- Main Product
- Tags
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8730Research, Development, And Testing Services
- 8731Commercial Physical and Biological Research
Show 13 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 2800Chemicals And Allied Products
- 8000Health Services
- 2830Drugs
- 8040Offices And Clinics Of Other Health Practitioners
- 2834Pharmaceutical Preparations
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified